GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$0.572
+0.0020 (+0.351%)
At Close: Apr 19, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 19th Apr 2024 ADXS stock ended at $0.572. This is 0.351% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $0.572 to a day high of $0.600.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2021-09-17 $0.502 $0.536 $0.502 $0.530 2 698 238
2021-09-16 $0.530 $0.536 $0.486 $0.523 6 379 391
2021-09-15 $0.561 $0.564 $0.526 $0.547 7 351 789
2021-09-14 $0.545 $0.595 $0.535 $0.545 13 921 719
2021-09-13 $0.581 $0.600 $0.522 $0.560 16 912 541
2021-09-10 $0.480 $0.645 $0.455 $0.600 83 498 578
2021-09-09 $0.475 $0.500 $0.450 $0.468 3 940 442
2021-09-08 $0.472 $0.484 $0.461 $0.474 2 203 336
2021-09-07 $0.492 $0.510 $0.465 $0.476 4 849 835
2021-09-03 $0.510 $0.524 $0.480 $0.504 17 483 570
2021-09-02 $0.477 $0.477 $0.453 $0.464 3 522 695
2021-09-01 $0.466 $0.486 $0.460 $0.470 4 571 024
2021-08-31 $0.450 $0.478 $0.448 $0.469 4 000 797
2021-08-30 $0.441 $0.465 $0.438 $0.448 4 216 943
2021-08-27 $0.441 $0.480 $0.435 $0.461 4 654 386
2021-08-26 $0.495 $0.518 $0.450 $0.469 23 637 922
2021-08-25 $0.426 $0.442 $0.410 $0.438 2 731 118
2021-08-24 $0.420 $0.446 $0.408 $0.424 3 384 212
2021-08-23 $0.399 $0.420 $0.394 $0.413 1 586 249
2021-08-20 $0.387 $0.409 $0.381 $0.399 1 616 973
2021-08-19 $0.406 $0.408 $0.384 $0.387 1 608 842
2021-08-18 $0.390 $0.420 $0.385 $0.408 2 797 668
2021-08-17 $0.410 $0.410 $0.383 $0.392 2 910 628
2021-08-16 $0.430 $0.430 $0.390 $0.398 3 275 577
2021-08-13 $0.430 $0.435 $0.420 $0.420 1 646 903
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Golden Star

Ticker Date Change Price
DOOR Apr 17 0.0305% $131.35
LNG Apr 17 3.29% $156.81
FCN Apr 16 1.75% $207.62
ELV Apr 16 4.82% $506.97
FTSL Apr 16 0.217% $46.08
AKR Apr 05 3.15% $16.53
ITCI Apr 05 5.74% $68.44
SARK Mar 28 18.79% $26.88
SON Mar 26 0.83% $56.64
ARCC Mar 25 2.34% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT